Merck stock rises ahead of earnings: MRK traders eye guidance and the Keytruda cliff
Merck shares rose 2.2% to $112.67 by midday Monday ahead of its quarterly earnings report due Tuesday. Analysts expect fourth-quarter revenue of $16.12 billion and adjusted earnings of $2.01 per share. The company will hold its earnings call at 9 a.m. ET. Investors are watching for updates on Keytruda and Merck’s 2026 outlook.